Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AstraZeneca Revitalizes Crestor With Atherosclerosis Ad Campaign

This article was originally published in The Pink Sheet Daily

Executive Summary

Company makes hay from Merck/Schering-Plough's failed Vytorin atherosclerosis trial.

You may also be interested in...



AstraZeneca’s GALAXY Studies And Plans For Crestor’s Ongoing Development

Company executives discuss on-going efforts to differentiate Crestor in the increasingly crowded cholesterol-lowering market.

AstraZeneca’s GALAXY Studies And Plans For Crestor’s Ongoing Development

Company executives discuss on-going efforts to differentiate Crestor in the increasingly crowded cholesterol-lowering market.

AstraZeneca Outlines Two-year Development, Debt Reduction Strategy

Anglo-Swiss pharma reports first quarter sales increases for Seroquel and Crestor; Nexium declines.

Related Content

Topics

UsernamePublicRestriction

Register

LL1134882

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel